COVID-19 pandemic in Lakshadweep explained

The first case of COVID-19 on the Union Territory of Lakshadweep was recorded on 18 January 2021.^[1] Lakshadweep Islands, until then, was India's only COVID-free territory (state/UT), and life was fairly normal for the residents of the UT.^[2] As of 13 September 2021, there were 10,297 confirmed cases (5 active) and 51 deaths.^[3]

Timeline

• As on 19 January, total number of cases in Lakshadweep was 21. All of them are active cases.

• As on 25 January, total number of cases was 67. All of them are active cases.

• As on 3 February, total number of cases was 122, including 61 active cases and 61 recoveries.

• As on 10 February, total number of cases was 178, including 63 active cases and 115 recoveries.
• As of 12 August 2021, there are 40 active cases.^[4] jk
  • As of 13 September 2021, total number of cases was 10,297, including 5 active cases and 51 deaths.

COVID-19 vaccines with approval for emergency or conditional usage

See main article: COVID-19 vaccination in India.

Two vaccines - University of Oxford’s AZD1222 (marketed as Covishield in India) and BBV152 (marketed as Covaxin, developed in India by Bharat Biotech in association with the ICMR and NIV) were approved by the Drug Controller General of India on 1 and 2 January 2021.^{[5] [6]} Both can be stored, transpedorted and handled at normal refrigerated conditions (2-8 degrees Celsius).

See also

• COVID-19 pandemic in India
• COVID-19 pandemic

Notes and References

1. Web site: Nearly a year after Covid-19 outbreak in India, Lakshadweep reports its first-ever case. 22 January 2021. India Today.
2. News: What Covid-19? Life is normal is Lakshadweep. 22 January 2021. Times of India. 9 December 2020.
3. Web site: MoHFW-Home. 22 January 2021. www.mohfw.gov.in.
4. News: PTI. 2021-08-13. Lakshadweep administration imposes travel restriction to mainland in view of rising COVID-19 cases in Kerala. en-IN. The Hindu. 2021-08-17. 0971-751X.
5. News: COVID-19 vaccine Covishield gets approval from DCGI's expert panel . 22 January 2021 . The Hindu . 1 January 2021.
6. News: Expert panel recommends Bharat Biotech's Covaxin for restricted emergency use . 22 January 2021 . News18 . 2 January 2021.